Article Details
Retrieved on: 2024-08-18 11:57:37
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Blue Trust Inc. significantly increasing its holdings in AstraZeneca during the second quarter. It highlights the impact of COVID-19 on AstraZeneca’s financial performance, dividends, stock analysis, and investment by institutional investors.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here